Alliancebernstein L.P. Puma Biotechnology, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 13,800 shares of PBYI stock, worth $67,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,800

Holding current value

$67,896

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.74 - $3.72 $37,812 - $51,336	13,800 New	13,800 $47,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $91,676 - $184,470	-55,900 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.13 - $3.24 $213 - $324	100 Added 0.18%	55,900 $161,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $16,815 - $38,822	-5,900 Reduced 9.56%	55,800 $170,000
Q1 2021 May 06, 2021	SELL	$9.38 - $13.63 $30,954 - $44,979	-3,300 Reduced 5.08%	61,700 $600,000
Q3 2020 Nov 12, 2020	SELL	$9.5 - $11.14 $84,550 - $99,146	-8,900 Reduced 12.04%	65,000 $656,000
Q2 2020 Aug 13, 2020	SELL	$7.01 - $13.24 $46,266 - $87,384	-6,600 Reduced 8.2%	73,900 $771,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $80,500 - $118,220	9,200 Added 12.9%	80,500 $867,000
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $314,880 - $915,456	25,600 Added 56.02%	71,300 $906,000
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $2.52 Million - $5.87 Million	-125,640 Reduced 73.33%	45,700 $930,000
Q3 2018 Nov 08, 2018	BUY	$41.2 - $59.85 $5.29 Million - $7.68 Million	128,300 Added 298.09%	171,340 $7.86 Million
Q2 2018 Aug 13, 2018	SELL	$48.3 - $68.25 $1.2 Million - $1.7 Million	-24,860 Reduced 36.61%	43,040 $2.55 Million
Q1 2018 May 14, 2018	BUY	$59.7 - $99.25 $425,661 - $707,652	7,130 Added 11.73%	67,900 $4.62 Million
Q4 2017 Feb 13, 2018	SELL	$93.85 - $132.45 $471,127 - $664,899	-5,020 Reduced 7.63%	60,770 $6.01 Million
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $4.74 Million - $7.88 Million	65,790	65,790 $7.88 Million

Others Institutions Holding PBYI

# of Institutions

126

Shares Held

33.6M

Call Options Held

68.2K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $224M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Puma Biotechnology, Inc. Transaction History